Ce produit n'est pas destiné à diagnostiquer, traiter, guérir ou prévenir toute maladie. Ces déclarations n'ont pas été évaluées par la Food and Drug Administration.
Ces informations sont fournies à titre éducatif uniquement et ne remplacent pas un avis médical professionnel, un diagnostic ou un traitement. Consultez toujours votre professionnel de santé avant d'utiliser des plantes, surtout si vous êtes enceinte, allaitez, prenez des médicaments ou avez une condition médicale.
Cette fiche a été compilée à partir de résumés PubMed (NIH) avec l'assistance d'une IA. Chaque affirmation factuelle est citée par un article PubMed réel (voir la liste des sources). Elle n'a pas encore été révisée par un humain — confirmez auprès d'un professionnel de santé avant utilisation.
Compilé à partir de 26 articles PubMed · modèle : gemma4:31b
Résumé
Ligustrum japonicum is a medicinal plant valued for its fruits and leaves, demonstrating potential anti-inflammatory, anti-osteoporotic, and neuroprotective activities [PMID:41515469, 33628272, 16450298].
Contexte
Ligustrum japonicum Thunb. (Oleaceae), also known as Japanese privet, is a shrub used in traditional medicinal practices [PMID:41515469, 33628272].
Usages traditionnels
The fruits are traditionally utilized in folk medicine, specifically in Korea and Japan [PMID:41515469, 33628272]. In traditional Chinese medicine, Fructus ligustri lucidi (which may include L. japonicum) is used to treat hepatitis and aging-related symptoms, while in traditional Korean medicine, it is used to detoxify the liver and kidneys [PMID:33918375].
Composés actifs
The plant contains secoiridoids, including oleonuezhenide, isonuezhenide [PMID:17269061], (8Z)-nuezhenide A, (8E)-nuezhenide, osmanthuside B, and osmanthuside D [PMID:16450298], as well as ligustroside and 8(E)-nuezhenide [PMID:35269801]. Other identified compounds include the phenyl ethanoid salidroside [PMID:35269801, 33628272], ligujaponosides A-B, iso-oleonuzhenide, and the nor-dammarane 3β,20,23-trihydroxy-24,25,26,27-tetranordammarane [PMID:28618355], and sesamin [PMID:28618355].
Mécanisme d'action
Compounds from L. japonicum fruits (GL-3, oleonuezhenide, salidroside, 8(E)-nuezhenide, and ligustroside) inhibit the expression and release of MMP-2 and MMP-9 via the MAPK pathway, specifically by decreasing phosphorylated p38, ERK, and JNK proteins [PMID:30744075, 35269801]. Salidroside enhances osteoblast differentiation through overactivation of the Wnt/BMP signaling pathway and suppresses adipocyte differentiation via the MAPK and PPARγ pathways [PMID:33628272]. Sesamin inhibits T cell activation by regulating MAPK phosphorylation, specifically inhibiting ERK phosphorylation [PMID:28618355].
Preuves cliniques
Preuve DHyperlipemia and Atherosclerosis
In rabbit models, L. japonicum (Var. Pubescens) lowered serum total lipids (TL), total cholesterol (TC), and LPO, and reduced the arteriosclerotic area of the aorta [PMID:7703637].
Preuve DOsteoporosis
L. japonicum fruits and salidroside enhanced osteoblast formation and suppressed adipogenesis in bone marrow-derived mesenchymal stromal cells [PMID:33628272].
Preuve DNeurotoxicity
Six secoiridoid glycosides from L. japonicum leaves significantly protected human neuroblastoma SH-SY5Y cells from 6-hydroxydopamine-induced neurotoxicity [PMID:16450298].
Preuve DTumor Metastasis (In vitro)
Secoiridoids and salidroside from L. japonicum fruits inhibited the expression of MMP-2 and MMP-9 in HT 1080 fibrosarcoma cells [PMID:30744075, 35269801].
Preuve DT cell activation
Sesamin isolated from L. japonicum fruits inhibited IL-2 production in Jurkat T cells [PMID:28618355].
Synthèse des preuves
The current evidence is based on in vitro cell studies and animal models (rabbits); there are no human clinical trials provided. The strength of evidence is low (Level D).
Sources PubMed
1.PMID: 41515469 (2026) — Organ-Specific Diversity of Secoiridoids in Ligustrum japonicum Thunb. · Molecules (Basel, Switzerland)
2.PMID: 30744075 (2019) — Evaluation of MMP Inhibitors Isolated from Ligustrum japonicum Fructus. · Molecules (Basel, Switzerland)
3.PMID: 17269061 (1987) — New Secoiridoid Glucosides from Ligustrum japonicum. · Planta medica
4.PMID: 35269801 (2022) — Salidroside, 8(E)-Nuezhenide, and Ligustroside from Ligustrum japonicum Fructus Inhibit Expressions of MMP-2 and -9 in HT 1080 Fibrosarcoma. · International journal of molecular sciences
5.PMID: 33628272 (2021) — Ligustrum japonicum Thunb. Fruits Exert Antiosteoporotic Properties in Bone Marrow-Derived Mesenchymal Stromal Cells via Regulation of Adipocyte and Osteoblast Differentiation.
Sources gouvernementales
Aucune monographie gouvernementale directe n'est disponible pour cette plante. Le contenu ci-dessous est généré par IA et n'a pas été vérifié par rapport à une source gouvernementale faisant autorité. Utilisez les liens de recherche pour consulter les sources officielles avant de vous fier à ces informations.
6.PMID: 33918375 (2021) — Anti-Neuroinflammatory Effects and Mechanism of Action of Fructus ligustri lucidi Extract in BV2 Microglia. · Plants (Basel, Switzerland)
7.PMID: 16450298 (2006) — A new neuroprotective compound of Ligustrum japonicum leaves. · Planta medica
8.PMID: 28618355 (2017) — Chemical constituents from the fruits of Ligustrum japonicum and their inhibitory effects on T cell activation. · Phytochemistry
9.PMID: 7703637 (1994) — [Preliminary study on pharmacologic action of Ligustrum japonicum]. · Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine